secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2021-10-28T23:59:59+00:00
Accession:  0001157523-21-001284
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AptarGroup Q3 revenue $825M (+9% YoY); adjusted EPS $0.94 vs $1.01; guides Q4 $0.88-$0.96
--------------------------------------------------------------------------------

- Reported sales $825M, +9% YoY; core sales +8%; Pharma core -2%, Beauty+Home +10%, Food+Beverage +28%.
- Reported EPS $0.70 (includes $0.12 restructuring, $0.10 unrealized loss on PureCycle investment, $0.02 acquisition costs); adjusted EPS $0.94.
- Adjusted EBITDA $154M; net income $47M.
- Completed acquisitions: 80% of Weihai Hengyu Medical Products and majority stake in Voluntis.
- Q4 2021 adjusted EPS guidance $0.88-$0.96; quarterly dividend $0.38/share payable Nov 17, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000115752321001284/0001157523-21-001284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000115752321001284/a52517971.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-001284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer